A randomized, multicenter trial assessing the effects of rapastinel compared to ketamine, alprazolam, and placebo on simulated driving performance.

Autor: Su, Shengfang, Kay, Gary, Hochadel, Thomas, Rojo, Jonathan, Christopher Stein, J., Boinpally, Ramesh, Periclou, Antonia

Publikováno v: CTS: Clinical & Translational Science; Jan2022, Vol. 15 Issue 1, p255-266, 12p

A randomized, multicenter trial assessing the effects of rapastinel compared to ketamine, alprazolam, and placebo on simulated driving performance.

Autor: Su S; Allergan plc (now AbbVie, Inc.), Madison, New Jersey, USA., Kay G; Cognitive Research Corporation, St. Petersburg, Florida, USA., Hochadel T; Cognitive Research Corporation, St. Petersburg, Florida, USA., Rojo J; Allergan plc (now AbbVie, Inc.), Madison, New Jersey, USA., Christopher Stein J; Allergan plc (now AbbVie, Inc.), Madison, New Jersey, USA., Boinpally R; Clinical Pharmacology, AbbVie, Inc., Madison, New Jersey, USA., Periclou A; Allergan plc (now AbbVie, Inc.), Madison, New Jersey, USA.

Publikováno v: Clinical and translational science [Clin Transl Sci] 2022 Jan; Vol. 15 (1), pp. 255-266. Date of Electronic Publication: 2021 Nov 07.